Abstract
Statement of Purpose: Over the past two years, there has been a discussion whether mesenchymal stem cells (MSCs) should be renamed as “medicinal signaling cells”. [1] This is an outcome of a paradigm shift in the understanding the role of MSCs in regenerative therapy, in which the paracrine signaling and cell-cell communications are the main approaches for the MSCs to exert their healing effects rather than relying on the engraftment and differentiation.
Original language | English |
---|---|
Title of host publication | Society for Biomaterials Annual Meeting and Exposition 2019 |
Subtitle of host publication | The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting |
Publisher | Society for Biomaterials |
Pages | 356 |
Number of pages | 1 |
ISBN (Electronic) | 9781510883901 |
Publication status | Published - 2019 |
Externally published | Yes |
Event | 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Seattle, United States Duration: Apr 3 2019 → Apr 6 2019 |
Publication series
Name | Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium |
---|---|
Volume | 40 |
ISSN (Print) | 1526-7547 |
Conference
Conference | 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence |
---|---|
Country/Territory | United States |
City | Seattle |
Period | 4/3/19 → 4/6/19 |
Bibliographical note
Publisher Copyright:© 2019 Omnipress - All rights reserved.
ASJC Scopus Subject Areas
- Biochemistry
- Biophysics
- Biotechnology
- Biomaterials
- Materials Chemistry